Chronic migraine in the first COVID-19 lockdown: the impact of sleep, remote working, and other life/psychological changes.
Chronic migraine in the first COVID-19 lockdown: the impact of sleep, remote working, and other life/psychological changes.
复制标题
DOI:
10.1007/s10072-021-05521-7
复制
发表时间:
2021-11
期刊:
影响因子:
--
通讯作者:
Autunno M
中科院分区:
文献类型:
--
作者:
Currò CT;Ciacciarelli A;Vitale C;Vinci ES;Toscano A;Vita G;Trimarchi G;Silvestri R;Autunno M
The objective of this study was to evaluate the impact of the first Italian COVID-19 lockdown on patients with chronic migraine (CM). The study was based on an e-mail survey addressed to CM patients of our headache center. The survey evaluated demographic, life style, sleep, psychological, and migraine features during the COVID-19 lockdown period and the month before. The outcomes were migraine impact on daily life and variation in attack frequency, attack duration, migraine pain intensity, migraine symptomatic drugs use per week, and efficacy. Ninety-two patients completed the survey. During the lockdown period, attack frequency was stable in 40,2%, increased in 33,7%, and reduced in 26,1% of patients; attack duration was stable in 55,4%, increased in 23,9%, and reduced in 20,7%. Migraine pain was stable or reduced in 65,2% and increased in 34,8%; number of symptomatic drugs per week was stable in 50%, reduced in 29,3%, and increased in 20,7%; migraine drug efficacy was stable in 73,9%, reduced in 17,4%, and increased in 8,7%. Patients had a HIT-6 score of 64,63 ± 8,81. Significant associations were found with remote working, smoke, education, discontinuation of the therapy performed within headache center, migraine familiarity, sleep, anxiety, perceived stress, concern about future, and COVID-19. During the lockdown, approximately half of the patients had a clinical stability, a quarter an improvement, and another quarter a worsening. We identified different migraine-influencing elements; in particular, the remote working could represent an easy way to ameliorate migraineurs’ life. The online version of this article contains supplementary material available (10.1007/s10072-021-05521-7).
登录
查看更多内容
DOI:
10.1016/s1474-4422(18)30387-9
发表时间:
2018-12
期刊:
The Lancet. Neurology
影响因子:
--
作者:
GBD 2016 Meningitis Collaborators
通讯作者:
GBD 2016 Meningitis Collaborators
影响因子:
3.3
作者:
Leonardi, M.;Raggi, A.
通讯作者:
Raggi, A.
DOI:
10.1007/s10072-020-04767-x
发表时间:
2020-12
期刊:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
影响因子:
--
作者:
Altamura C;Cevoli S;Aurilia C;Egeo G;Fofi L;Torelli P;Brunelli N;Pierangeli G;Favoni V;Fallacara A;Pensato U;Barbanti P;Vernieri F
通讯作者:
Vernieri F
影响因子:
3.4
作者:
Dallavalle G;Pezzotti E;Provenzi L;Toni F;Carpani A;Borgatti R
通讯作者:
Borgatti R
影响因子:
3.4
作者:
Delussi M;Gentile E;Coppola G;Prudenzano AMP;Rainero I;Sances G;Abagnale C;Caponnetto V;De Cesaris F;Frattale I;Guaschino E;Marcinnò A;Ornello R;Pistoia F;Putortì A;Roca ME;Roveta F;Lupi C;Trojano M;Pierelli F;Geppetti P;Sacco S;de Tommaso M
通讯作者:
de Tommaso M